RS-Glucoraphanin bioactivated with myrosinase treatment counteracts proinflammatory cascade and apoptosis associated to spinal cord injury in an experimental mouse model

Taken together, our results show that MYR-activated RS-GRA could represent an interesting approach for the management of secondary damage following SCI.